From: 9th European Conference on Rare Diseases & Orphan Products (ECRD Vienna 2018)
Mode of treatment | Remission rates (% of patients) | Total number of patients |
---|---|---|
Overall | 51.4 | 534 |
Overall after introduction of SSA | 70.3 | 219 |
Surgery | 28.8 | 486 |
Adjuvant CAB without prior Ro | 18.2 | 70 |
Adjuvant SSA | 38.6 | 70 |
Conventional radiotherapy | 34.6 | 159 |